Literature DB >> 33123977

Effect of adjunctive hormonal therapy on testicular descent and spermatogenic function among children with cryptorchidism: a systematic review and meta-analysis.

Kaiping Zhang1, Yin Zhang1, Min Chao2.   

Abstract

OBJECTIVES: To systematically evaluate the effect of adjunctive hormonal therapy on testicular descent and spermatogenic function among children with cryptorchidism.
METHODS: A comprehensive literature search of electronic databases up to February 21, 2019 was performed. Continuous data of fertility indices were evaluated using weighted mean difference (WMD) with 95% confidence interval (CI), while nominal data of fertility indices and the complete descent rates were analyzed by risk ratio (RR) with 95% CI. A fixed effect or random effect model was used.
RESULTS: A total of 27 previous studies were included for the current analysis. Hormonal therapy increased complete testicular descent rate, reaching statistical significance (RR = 3.74; 95% CI, 2.78-5.04; P < 0.001). The success rate was 22.43%. A similar result was found in subgroup analysis of hormonal category and effect on unilateral or bilateral cryptorchidism. Studies reporting primary outcome as continuous data showed that cryptorchid males have significantly increased germ cell numbers per tubule (WMD = 0.10; 95% CI, 0.01-0.20, P = 0.032) after hormonal therapy. The nominal data of pooled studies showed no significant difference (RR = 1.62; 95% CI, 0.65-4.00, P = 0.298). In addition, a significant result was noted in the luteinizing hormone-releasing hormone (LHRH) therapy group but not in those undergoing human chorionic gonadotropin (hCG) treatment.
CONCLUSIONS: Our findings have demonstrated that hormonal therapy can effectively increase the success rate of complete testicular descent, while some boys may benefit as regards improvement of the fertility index.

Entities:  

Keywords:  Cryptorchidism; Hormonal therapy; Meta-analysis; Spermatogenic function; Testicular descent

Year:  2020        PMID: 33123977     DOI: 10.1007/s42000-020-00244-4

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  47 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

3.  Meta-analysis of genetic association studies.

Authors:  Marcus R Munafò; Jonathan Flint
Journal:  Trends Genet       Date:  2004-09       Impact factor: 11.639

4.  Prospective study on the prevalence and associated risk factors of cryptorchidism in 6246 newborn boys from Nice area, France.

Authors:  K Wagner-Mahler; J-Y Kurzenne; I Delattre; E Bérard; J-C Mas; L Bornebush; C Tommasi; M Boda-Buccino; B Ducot; C Boullé; P Ferrari; P Azuar; A Bongain; P Fénichel; F Brucker-Davis
Journal:  Int J Androl       Date:  2011-08-10

5.  Publication bias and dissemination of clinical research.

Authors:  C B Begg; J A Berlin
Journal:  J Natl Cancer Inst       Date:  1989-01-18       Impact factor: 13.506

Review 6.  Germ cell development in the descended and cryptorchid testis and the effects of hormonal manipulation.

Authors:  C Ong; S Hasthorpe; J M Hutson
Journal:  Pediatr Surg Int       Date:  2005-02-23       Impact factor: 1.827

Review 7.  Efficacy and safety of hormonal treatment of cryptorchidism: current state of the art.

Authors:  Arni V Thorsson; Peter Christiansen; Martin Ritzén
Journal:  Acta Paediatr       Date:  2007-05       Impact factor: 2.299

8.  Evaluation and treatment of cryptorchidism: AUA guideline.

Authors:  Thomas F Kolon; C D Anthony Herndon; Linda A Baker; Laurence S Baskin; Cheryl G Baxter; Earl Y Cheng; Mireya Diaz; Peter A Lee; Carl J Seashore; Gregory E Tasian; Julia S Barthold
Journal:  J Urol       Date:  2014-05-20       Impact factor: 7.450

Review 9.  Nordic consensus on treatment of undescended testes.

Authors:  E Martin Ritzén; A Bergh; R Bjerknes; P Christiansen; D Cortes; S E Haugen; N Jörgensen; C Kollin; S Lindahl; G Läckgren; K M Main; A Nordenskjöld; E Rajpert-De Meyts; O Söder; S Taskinen; A Thorsson; J Thorup; J Toppari; H Virtanen
Journal:  Acta Paediatr       Date:  2007-02-26       Impact factor: 2.299

10.  Cryptorchidism at birth in Nice area (France) is associated with higher prenatal exposure to PCBs and DDE, as assessed by colostrum concentrations.

Authors:  Françoise Brucker-Davis; Kathy Wagner-Mahler; Isabelle Delattre; Béatrice Ducot; Patricia Ferrari; André Bongain; Jean-Yves Kurzenne; Jean-Christophe Mas; Patrick Fénichel
Journal:  Hum Reprod       Date:  2008-05-24       Impact factor: 6.918

View more
  1 in total

1.  16 years follow-up evaluation of immediate vs delayed vs. combined hormonal therapy on fertility of patients with cryptorchidism: results of a longitudinal cohort study.

Authors:  Riccardo Bartoletti; Antonio Luigi Pastore; Filippo Menchini Fabris; Tommaso Di Vico; Riccardo Morganti; Andrea Mogorovich; Girolamo Morelli; Diego Peroni; Yazan Al Salhi; Alessandro Zucchi
Journal:  Reprod Biol Endocrinol       Date:  2022-07-14       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.